Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge
- 1 July 2005
- Vol. 23 (31) , 4036-4047
- https://doi.org/10.1016/j.vaccine.2005.03.013
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of virology and immunology in SHIV 89.6 proviral DNA and virus‐inoculated rhesus macaquesJournal of Medical Primatology, 2003
- Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon ResponsesJournal of Virology, 2003
- Live attenuated AIDS viruses as vaccines: promise or peril?Immunological Reviews, 1999
- Viremia and AIDS in Rhesus Macaques after Intramuscular Inoculation of Plasmid DNA Encoding Full-Length SIVmac239AIDS Research and Human Retroviruses, 1999
- Infection of Cats by Injection with DNA of a Feline Immunodeficiency Virus Molecular CloneVirology, 1997
- Comparative Efficiency of Feline Immunodeficiency Virus Infection by DNA InoculationAIDS Research and Human Retroviruses, 1997
- Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal MucosaVirology, 1997
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992
- Risks of handling HIVNature, 1991